| |
 |
AMA PRA Category 1 Credit(s)™
Release Date 1/24/2014
Expiration Date 1/24/2015 |
|
|
| |
|
|
| |
 |
Kimberly A. Brown, MD (Chair)
Henry Ford Hospital
Detroit, MI
|
|
| |
 |
|
| |
|
|
| |
 |
Robert S. Brown, Jr., MD, MPH
New York Presbyterian
New York, NY |
|
| |
|
|
| |
|
|
| |
 |
Steven L. Flamm, MD
Northwestern University
Chicago, IL |
|
| |
|
|
| |
|
|
| |
 |
Kris V. Kowdley, MD
Virginia Mason Medical Center
Seattle, WA |
|
| |
|
|
| |
|
|
| |
|
|
| |
 |
|
| |
|
|
| |
|
|
| |
|
| |
|
|
|
|
|
| |
| Target Audience |
| This activity has been designed to meet the educational needs of hepatologists, gastroenterologists and healthcare providers involved in the care of patients with cirrhosis. |
| |
| Goal Statement |
| The primary goal of this CME symposium is to better understand how to effectively manage and treat patients with cirrhosis based on current guidelines and the latest clinical evidence. |
| |
| Educational Objectives |
| After completing this activity, the participants should be better able to: |
|
• |
Discuss the natural history and complications of cirrhosis including management options |
| • |
Review the diagnosis and treatment of overt hepatic encephalopathy and recognize the importance of initiating prophylactic therapy following an episode of overt hepatic encephalopathy |
| • |
Apply the latest clinical data and management guidelines into clinical practice |
|
| |
| Physician Accreditation
Statement |
| This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The University of Cincinnati College of Medicine and the Chronic Liver Disease Foundation. The University of Cincinnati College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
| |
| Credit Designation |
| The University of Cincinnati College of Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
| |
| Disclosure |
It is the policy of The University of Cincinnati College of Medicine to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.
The University of Cincinnati College of Medicine assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME/CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by The University of Cincinnati College of Medicine for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The University of Cincinnati College of Medicine is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest or a commercial interest.
In accordance with the ACCME Standards, parallel documents from other accrediting bodies, The University of Cincinnati College of Medicine policy, the following disclosures have been made: The faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications. All staff at the University of Cincinnati College of Medicine have nothing to disclose.
|
| |
 |
| |
|
